Abiopharma

Clinical trial NCT06085924: enrollment: 8252912 → 2315187 participants.

Clinical trial NCT07565545: enrollment: 110 → 120 participants.

Clinical trial NCT03247023 updates: 1. primary completion date: 2021-12-08 → 2023-09-06 2. enrollment: 61 → 65 participants

Clinical trial NCT07277582: start date: 2026-03-31 → 2026-03-07.

Clinical trial NCT03974113: phase: PHASE3 → PHASE2.

Clinical trial NCT07063511 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-08-02 → 2026-06-22 3. primary completion date: 2026-07-02 → 2026-05-22

Clinical trial NCT07524257 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 494 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07431866 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-13 → 2026-06-11 3. primary completion date: 2026-06-13 → 2026-06-11 4. enrollment: 39 → 41 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05199701 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-03-31 → 2026-11-05 3. primary completion date: 2026-03-31 → 2026-11-05

Clinical trial NCT03675893 updates: 1. enrollment: 180 → 110 participants 2. collaborators removed: Effector Therapeutics